SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 21
Posts 4,098
Boards Moderated 0
Alias Born 06/15/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/25/2016 4:05:51 PM
ARIAD Announces Appointment of Jennifer L. Herron as Chief Commercial Officer "Business Wire" - 5/24/2016 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/20/2016 9:28:49 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2016 4:12:48 PM
ARIAD Announces Pricing and Reimbursement for Iclusig in France "Business Wire" - 5/19/2016 7:35:00 AM
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting "Business Wire" - 5/18/2016 5:08:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/13/2016 6:01:26 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2016 5:11:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 5/10/2016 11:01:16 AM
Incyte y ARIAD anuncian un acuerdo según el cual Incyte adquiere los derechos de licencia de Iclusig® (ponatinib) y las ope... "Business Wire" - 5/10/2016 8:16:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/10/2016 7:46:55 AM
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review "Business Wire" - 5/10/2016 7:35:00 AM
Incyte et ARIAD annoncent un accord dans le cadre duquel Incyte rachètera les opérations européennes d'ARIAD et vendra sou... "Business Wire" - 5/10/2016 5:38:00 AM
Incyte und ARIAD geben Vereinbarung zur Übernahme des europäischen Geschäfts von ARIAD durch Incyte und die Einlizenzierun... "Business Wire" - 5/9/2016 12:37:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2016 7:17:20 AM
Incyte & ARIAD Announce Agreement for Incyte to Acquire ARIAD’s European Operations & In-license Iclusig® (ponatinib) in E... "Business Wire" - 5/9/2016 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/6/2016 5:01:19 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/6/2016 4:59:08 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 5/6/2016 4:55:42 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 5/6/2016 4:53:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/6/2016 4:11:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/2/2016 5:43:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/2/2016 5:43:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/2/2016 5:42:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/2/2016 5:42:36 PM
vidpok45   Tuesday, 05/15/12 08:11:15 PM
Re: ariadndndough post# 18930
Post # of 73191 
That would be logical once the anecdotal reports can be validated.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist